权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Humanized mice to study mast cell function

研究肥大细胞功能的人源化小鼠

基本信息

批准号：
8643443
负责人：
Hydar Ali
金额：
$ 20万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-04-15 至 2016-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8643443
关键词：
ADRBK1 gene ADRBK2 gene Acute Affinity Agonist Allergens Allergic Allergic Disease Allergic rhinitis Anaphylatoxins Anaphylaxis Animal Model Antigen-Antibody Complex Antigens Asthma Atherosclerosis Autoimmune Diseases Bronchoalveolar Lavage Fluid Bronchoconstriction Bulla CD34 gene Cell Degranulation Cell physiology Cell surface Cells Cleaved cell Collaborations Complement 3a Complement 5a Complement Activation Complement Membrane Attack Complex Complex Data Development Disease Experimental Models G protein coupled receptor kinase G-Protein-Coupled Receptors GRK5 gene GRK6 gene Generations Genetic Growth Factor Host Defense Human IgE IgE Receptors Immune Immune system Inflammation Inflammatory Inflammatory Response Laboratories Lead Lung Lytic Mediating Mediator of activation protein Methods Mouse Strains Mus Natural Immunity Neoplasm Metastasis Passive Cutaneous Anaphylaxis Pathogenesis Pathway interactions Pattern Recognition Systems Periodontal Diseases Phosphorylation Plasma Play Predisposition Protein Tyrosine Kinase Proteins Reaction Receptor Gene Receptor Signaling Regulation Relative (related person)Research Personnel Rheumatoid Arthritis Rodent Rodent Model Role Signal Pathway Signal Transduction Single Nucleotide Polymorphism Skin Slice Surface Antigens Testing Therapeutic Tryptase Umbilical Cord Blood Work airway inflammation allergic response arrestin 1 base complement C3 precursor complement system genetic manipulation in vivo in vivo Model mast cell microbial mouse development mouse model novel novel strategies novel therapeutic intervention pathogen progenitor protein expression public health relevance pulmonary vascular permeability receptor response small hairpin RNA therapy development

项目摘要

DESCRIPTION (provided by applicant): Mast cells are multifunctional immune cells that play an important role in host defense but also promote asthma, allergic rhinitis, rheumatoid arthritis, atherosclerosis, skin-blistering diseases, cancer metastasis and are implicated in periodontal disease. There are important phenotypic and functional differences between human and rodent mast cells. Not surprisingly, therapeutic approaches developed using rodent models for mast cell-mediated disease such as asthma lack efficacy in humans. Thus, to better understand the mechanisms of mast cell-mediated diseases, it is critical to utilize in vivo models that are relevant to humans. In this proposal, the major objective is to develop a humanized mouse model for the genetic manipulation of human mast cell function in vivo. Aggregation of high affinity IgE receptors (Fc¿RI) on mast cells leads to the generation of C3a, which causes substantial degranulation in human mast cells and likely contributes to IgE-mediated allergic responses in vivo. Recent studies performed in our laboratory have identified novel signaling pathways via which G protein coupled receptor kinases (GRK5, GRK6) and adapter molecules ¿-arrestin 1 and Na+/H+ exchange regulatory factors (NHERF1 and NHEFR2) contribute to C3a-induced mast cell degranulation. We have also shown that GRK2 and GRK3 desensitize C3a-induced responses via the agonist-induced phosphorylation of C3aR. Given that C3a likely contributes to IgE-mediated responses in vivo, we hypothesize that modulation of C3aR signaling in mast cells regulates allergic responses ex vivo and in vivo. In aim #1, we will optimize conditions for the differentiation of human CD34+ cells into functional human mast cells in two strains of immune-deficient mice expressing growth factors for human mast cells. We will then target one protein that contributes to (NHERF1) and one that inhibits (GRK3) C3a-induced mast cell degranulation. Lentiviral shRNA will be used to silence the expression of these proteins in human cord blood- derived CD34+ cells and engrafted into immune deficient mice for the development of genetically manipulated human mast cells in vivo. We will use this novel approach as a "proof of concept" study to test the idea that genetic manipulation of human mast cells in vivo can be used to modulate bronchoconstriction ex vivo. C3aR expressed in mouse mast cells contribute to experimental passive cutaneous anaphylaxis (PCA) but not passive systemic anaphylaxis (PSA). In aim #2, we will utilize humanized mice to test the hypothesis that the presence of C3a-responsive human mast cells in the lung contributes to increased vascular pulmonary permeability in PSA. We will engraft NHERF1 or GRK3-silenced human CD34+ cells into immune deficient mice and test their impact on PCA and PSA reactions in vivo. We believe that genetic manipulation of human mast cells in humanized mice will provide a better understanding of their role in allergic and non-allergic diseases and may eventually lead to the development of novel treatment options.

描述（由申请人提供）：肥大细胞是多功能免疫细胞，在宿主防御中起重要作用，但也促进哮喘，变应性鼻炎，类风湿关节炎，